Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Gut Microbiome: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | Gut Microbiome |
| Key Genes/Proteins | AGING, AHR, AKT, Alpha-Synuclein, ALPHA-SYNUCLEIN, ALS |
| Related Diseases | Aging, Als, Alzheimer, Alzheimer'S Disease |
| Linked Hypotheses | 2 hypotheses |
Knowledge base pages for this entity
graph TD
Gut_Microbiome["Gut Microbiome"]
Neurodegeneration_Progression["Neurodegeneration Progression"]
Gut_Microbiome -->|"modulates"| Neurodegeneration_Progression
Als{"Als"}
Als -->|"activates"| Gut_Microbiome
INFLAMMATION(["INFLAMMATION"])
INFLAMMATION -->|"activates"| Gut_Microbiome
Inflammation{"Inflammation"}
Inflammation -->|"activates"| Gut_Microbiome
style Gut_Microbiome fill:#1a3a4a,stroke:#90a4ae,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Short-Chain Fatty Acids | associated_with | compound | 0.95 |
| Neurodegenerative Diseases | contributes_to | disease | 0.95 |
| Brain | interacts_with | brain_region | 0.95 |
| Neurological Disorders | associated_with | disease | 0.90 |
| Parkinson'S Disease | associated_with | disease | 0.90 |
| Immune Dysregulation | contributes_to | process | 0.85 |
| Brain | mediates | brain_region | 0.85 |
| Neurodegenerative Disorders | associated_with | disease | 0.85 |
| Parkinson's disease | implicated_in | disease | 0.80 |
| Alzheimer's disease | implicated_in | disease | 0.80 |
| Neurodegeneration Progression | modulates | phenotype | 0.75 |
| gut-liver-brain axis | regulates | pathway | 0.70 |
| Taurocholic acid | regulates | compound | 0.70 |
| Neuroinflammation | regulates | process | 0.70 |
| Neurodegeneration | modulates | process | 0.70 |
| Alzheimer'S Disease | associated_with | disease | 0.70 |
| Neurodegeneration | correlates_with | process | 0.70 |
| Telomere | activates | pathway | 0.50 |
| Pain | interacts_with | disease | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| CHRONIC INFLAMMATION | interacts_with | concept | 0.50 |
| Reactive Oxygen Species | activates | process | 0.50 |
| SYNUCLEIN | associated_with | concept | 0.50 |
| SYNUCLEIN | interacts_with | concept | 0.50 |
| SYNUCLEIN | activates | concept | 0.50 |
| CYTOKINE | regulates | concept | 0.50 |
| CENTRAL NERVOUS SYSTEM | associated_with | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| SDA-2026-04-01-gap-20260401-225155 | investigates | analysis | 0.95 |
| 35248147 | plays role in | paper | 0.90 |
| Circadian Rhythm | regulates | process | 0.90 |
| Als | activates | disease | 0.90 |
| Inflammation | activates | disease | 0.90 |
| Inflammation | associated_with | disease | 0.90 |
| INFLAMMATION | associated_with | gene | 0.90 |
| INFLAMMATION | activates | gene | 0.90 |
| Als | therapeutic_target | disease | 0.90 |
| Inflammation | regulates | disease | 0.80 |
| PARKINSON | associated_with | gene | 0.80 |
| Alzheimer | associated_with | disease | 0.80 |
| INFLAMMATION | regulates | gene | 0.80 |
| ALZHEIMER | associated_with | gene | 0.80 |
| Inflammation | therapeutic_target | disease | 0.80 |
| Cancer | therapeutic_target | disease | 0.80 |
| INFLAMMATION | therapeutic_target | gene | 0.80 |
| Parkinson | associated_with | disease | 0.80 |
| NEURODEGENERATION | activates | gene | 0.70 |
| Neurodegeneration | activates | disease | 0.70 |
| PARKINSON'S DISEASE | associated_with | gene | 0.70 |
| NEUROINFLAMMATION | activates | gene | 0.70 |
| MICROGLIA | activates | gene | 0.70 |
| Neuroinflammation | activates | disease | 0.70 |
| CANCER | therapeutic_target | gene | 0.70 |
| Als | causes | disease | 0.70 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.70 |
| Cardiovascular | therapeutic_target | disease | 0.70 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 0.70 |
| Als | associated_with | disease | 0.70 |
| Aging | therapeutic_target | disease | 0.70 |
| NEURODEGENERATION | implicated_in | gene | 0.60 |
| HUNTINGTON | implicated_in | gene | 0.60 |
| DEMENTIA | implicated_in | gene | 0.60 |
| CX3CR1 | implicated_in | gene | 0.60 |
| AMYOTROPHIC LATERAL SCLEROSIS | implicated_in | gene | 0.60 |
| NEUROINFLAMMATION | implicated_in | gene | 0.60 |
| MICROGLIA | implicated_in | gene | 0.60 |
| Huntington | implicated_in | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | implicated_in | disease | 0.60 |
| Neurodegeneration | implicated_in | disease | 0.60 |
| Dementia | implicated_in | disease | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| GAIN | causes | gene | 0.60 |
| CANCER | activates | gene | 0.60 |
| DNA | activates | gene | 0.60 |
| Tumor | activates | disease | 0.60 |
| Colorectal Cancer | activates | disease | 0.60 |
| Cancer | activates | disease | 0.60 |
| AHR | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming | 0.907 | neurodegeneration | What are the mechanisms by which gut mic |
| Cross-Seeding: Gut Microbiome-Derived Bacterial Curli and Fu | 0.540 | neurodegeneration | How does gut microbiome dysbiosis contri |
| plasma LPS-binding protein separates causal from compensator | 0.346 | neurodegeneration | How does gut microbiome dysbiosis contri |
| TLR4 priming is the actionable driver in: How does gut micro | 0.343 | neurodegeneration | How does gut microbiome dysbiosis contri |
| microglial inflammasome tone defines the therapeutic window | 0.341 | neurodegeneration | How does gut microbiome dysbiosis contri |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Iron and the Intestinal Microbiome. [PMID:40603801] | Li H | Adv Exp Med Biol | 2025 | 0 |
| Renal denervation attenuates cardiac dysfunction in HFpEF by inhibiting the ATP- [PMID:40958035] | Li Z, Sun X, Wang Y | Basic Res Cardiol | 2025 | 0 |
| Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and [PMID:38552431] | Wang W, Wang Y, Wang F, Xie G, Liu S, Li | Phytomedicine : international | 2024 | 0 |
| Joint-specific memory, resident memory T cells and the rolling window of opportu [PMID:38600215] | Chang MH, Fuhlbrigge RC, Nigrovic PA | Nat Rev Rheumatol | 2024 | 0 |
| Oral Microbiome: A Review of Its Impact on Oral and Systemic Health. [PMID:39338471] | Rajasekaran JJ, Krishnamurthy HK, Bosco | Microorganisms | 2024 | 0 |
| Gastrodin regulates the TLR4/TRAF6/NF-κB pathway to reduce neuroinflammation and [PMID:38552431] | Wang W, Wang Y, Wang F, Xie G, Liu S, Li | Phytomedicine : international | 2024 | 0 |
| Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting n [PMID:36601662] | ["Zhang Di", "Jing Bei", "Chen Zhen-Ni", | CNS neuroscience & therapeutic | 2023 | 0 |
| Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation [PMID:37435081] | Park, Hwang, Lee, Jang, Jeong et al. | Frontiers in immunology | 2023 | 0 |
| The role of the microbiota in glaucoma. [PMID:37866106] | Huang L, Hong Y, Fu X, Tan H, Chen Y, Wa | Molecular aspects of medicine | 2023 | 0 |
| Lomerizine inhibits LPS-mediated neuroinflammation and tau hyperphosphorylation [PMID:37435081] | Unknown | Frontiers in immunology | 2023 | 0 |
| Ferulic acid alleviates sciatica by inhibiting neuroinflammation and promoting n [PMID:36601662] | ["Zhang Di", "Jing Bei", "Chen Zhen-Ni", | CNS neuroscience & therapeutic | 2023 | 0 |
| The role of the microbiota in glaucoma. [PMID:37866106] | Huang L, Hong Y, Fu X, Tan H, Chen Y, Wa | Molecular aspects of medicine | 2023 | 0 |
| The role of Toll-like receptors and neuroinflammation in Parkinson's disease. [PMID:35668422] | ["Heidari Arash", "Yazdanpanah Niloufar" | Journal of neuroinflammation | 2022 | 0 |
| Pyroptosis in acute pancreatitis and its therapeutic regulation. [PMID:35687256] | Al Mamun A, Suchi SA, Aziz MA | Apoptosis | 2022 | 0 |
| Microglia in multiple sclerosis: Protectors turn destroyers. [PMID:35882229] | Yong | Neuron | 2022 | 0 |
| Microglia in multiple sclerosis: Protectors turn destroyers. [PMID:35882229] | Unknown | Neuron | 2022 | 0 |
| The role of Toll-like receptors and neuroinflammation in Parkinson's disease. [PMID:35668422] | ["Heidari Arash", "Yazdanpanah Niloufar" | Journal of neuroinflammation | 2022 | 0 |
| TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory sign [PMID:33057840] | ["Ciesielska A", "Matyjek M", "Kwiatkows | Cellular and molecular life sc | 2021 | 0 |
| Neuroinflammation in neurodegenerative disorders: the roles of microglia and ast [PMID:33239064] | Kwon, Koh | Translational neurodegeneratio | 2021 | 0 |
| AIM2 in regulatory T cells restrains autoimmune diseases. [PMID:33505023] | Chou WC, Guo Z, Guo H | Nature | 2021 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Gut Microbiome in their description or question text
No additional research found